Surgery for stubborn granulomatous breast inflammation
Part of Women’s health & pregnancy clinical trials.
This study looks at surgical treatment for granulomatous lobular mastitis that has not been improving with non-surgical care. It may help people with more widespread or complicated breast inflammation, especially when there are abscesses or skin breakdown.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have granulomatous lobular mastitis (a specific type of breast inflammation)
- You have not had surgery for this condition yet
- Your breast involvement is more extensive (two or more breast areas) or has complications like an abscess, draining tunnel (sinus), fistula, or skin rupture
- A doctor confirmed your diagnosis as granulomatous lobular mastitis, not another clear cause by pathology (tissue testing)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different surgical methods for treating granulomatous mastitis, a rare inflammatory breast condition. It aims to find which approach works best for patients who can safely have surgery.
This study looks at a non-surgical (“conservative”) approach to treating granulomatous lobular mastitis, along with help for mental health symptoms. It may help people whose breast inflammation and mental health concerns happen together.
This study looks at different ways to treat granulomatous lobular mastitis (GLM), a type of breast inflammation that is not an infection. The goal is to find which treatment works best for people with this condition.
This study compares two common treatments—antibiotics and steroids—to see which works better for a rare breast inflammation condition called granulomatous lobular mastitis (GLM). It aims to find the most effective and safe option for women with this condition.
This trial tests tocilizumab, a medication that reduces inflammation, for granulomatous lobular mastitis (GLM)—a rare, persistent breast inflammation. If your GLM hasn't responded to steroid therapy or you can't tolerate steroids, this study may help reduce inflammation and symptoms.
This study is creating a registry (a database) for people with a rare inflammatory breast condition called granulomatous mastitis. It aims to learn more about the disease and how it affects people, without testing any new treatments.
Hear when a new Refractory Granulomatous Lobular Mastitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.